Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    neurology

    Myasthenia gravis

    Also known as: MG, autoimmune myasthenia gravis, ocular myasthenia gravis, generalised myasthenia gravis

    Myasthenia gravis is an autoimmune neuromuscular-junction disorder characterised by fluctuating, fatigable weakness, including ptosis, diplopia, and sometimes swallowing or respiratory impairment. Pathogenic antibodies impair neuromuscular transmission; antibody results require clinical interpretation. Diagnosis, monitoring, and management remain neurologist-led. Chinese medicine assessment may offer an adjunctive framework for supportive care in medically stable patients, but traditional patterns do not correspond to biomedical subtypes or disease severity. The cited literature describes a fragmented, methodologically limited research base and provides no direct evidence establishing acupuncture or the listed formulas as effective for myasthenia gravis. Supportive interventions must never delay assessment of deterioration or replace prescribed pharmacotherapy, thymectomy when indicated, or emergency care.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Coordinate strenuous activities with periods of peak muscular strength and prioritise rest prior to the onset of exhaustion.
    • •Avoid hyperthermia and modulate activity levels in accordance with symptomatic fluctuations and multidisciplinary rehabilitation guidance.
    • •Consume meals during periods of adequate rest; masticatory fatigue, coughing during deglutition, or unintended weight loss should be reported to a medical practitioner for formal assessment rather than self-initiating dietary texture modifications.
    • •Maintain an accurate pharmacological record and consult a pharmacist or neurologist prior to the introduction of any herbal medicine, nutritional supplement, or new pharmaceutical agent.

    Cautions & Contraindications

    See sources
    • •Do not use TCM to replace neurological diagnosis, prescribed MG treatment or escalation for worsening weakness. The supplied TCM publication review does not establish efficacy or safety of these interventions.[,]
    • •Pregnancy and childhood require specialist-led individualisation; do not infer that herbal treatment is safer than prescribed medicines. Avoid routine abdominal needling in pregnancy and obtain pregnancy-specific acupuncture advice. The source supports population caution, not point-specific safety claims.[]
    • •Defer elective acupuncture and herbal changes during suspected cardiac involvement pending medical assessment. The cardiac review supports vigilance, but does not establish acupuncture or herbal safety in this population.[]
    • •Do not begin a formula without checking product identity, quality and the complete medicine list. Interactions with immunosuppressants, anticoagulants and other treatments need pharmacist review; the supplied review identifies safety and quality-control gaps rather than validating particular combinations.[]

    When to reassess or seek care again

    See sources

    Record baseline MG-ADL where clinically appropriate, fatigue rated 0–10, sleep, meal tolerance and any adverse effects. Review supportive care after 2–4 weeks, using comparable times of day and medicine timing. Stop or revise care if there is no meaningful agreed benefit. Any new bulbar, respiratory or rapidly generalising weakness overrides the review schedule and requires urgent medical assessment; do not attribute change solely to a TCM pattern.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Intractable & rare diseases research · 2026
    2. Frontiers in immunology · 2026
    3. Clinical and investigative medicine. Medecine clinique et experimentale · 2026
    4. Medicine · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.